Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Antiviral Therapy|August 3, 2007
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 diseaseAssia Samri, Ruth Goodall, Catherine Burton, et al.
Journal of Leukocyte Biology|April 1, 2005
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjectsAnthony Kebba, Justin Stebbing, Samantha Rowland, et al.
Vaccine|January 20, 2016
Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopesTina Ahmed, Nicola J Borthwick, Jill Gilmour, et al.
Proteomics|July 18, 2021
Selective HLA restriction enables the evaluation and interpretation of immunogenic breadth at comparable levels to that observed with broader HLA distributionJonathan Hare, Andrew Fiore-Gartland, Edward McGowan, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
Vaccine|May 6, 2008
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunizationLindvi Gudmundsdotter, Ann-Charlotte Boström, Catherine Burton, et al.
Blood|May 17, 2003
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptorJustin Stebbing, Brian Gazzard, Simon Portsmouth, et al.
Cell Research|July 1, 2004
Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patientsJustin Stebbing, Steve Patterson, Simon Portsmouth, et al.
AIDS Research and Treatment|April 15, 2011
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyJennifer Serwanga, Susan Mugaba, Auma Betty, et al.
Vaccine|December 3, 2014
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infectionAnna Herasimtschuk, Jocelyn Downey, Mark Nelson, et al.
Pageof 18